AGAP2 Antibody, Novus Biologicals™

AGAP2

Polyclonal

Unconjugated

0.2 ml PBS and 0.05% BSA with 0.05% Sodium Azide

AGAP2

A portion of amino acids 450-500 of human AGAP2 was used as the immunogen.

0.025 mg

Apoptosis

116986

Human, Mouse, Rat, Equine, Primate

IgG

Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), KnockDown

0.5 mg/mL

Western Blot 1-3 ug/ml, Immunohistochemistry, Immunocytochemistry/Immunofluorescence reported in scientific literature (PMID 34411567), Immunohistochemistry-Paraffin 5 ug/ml, KnockDown Validated reported in scientific literature (PMID 34411567)

AGAP-2, ArfGAP with GTPase domain, ankyrin repeat and PH domain 2, arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2, centaurin, gamma 1, centaurin-gamma-1, CENTG1, Cnt-g1, FLJ16430, GGAP2, GTP-binding and GTPase activating protein 2, GTP-binding and GTPase-activating protein 2, KIAA0167, Phosphatidylinositol-3-kinase enhancer, phosphoinositide 3-kinase enhancer, PIKEArf GAP with GTP-binding protein-like, ANK repeat and PH domains 2

Rabbit

Affinity Purified

RUO

Primary

The amino acid sequence used as immunogen is 100% homologous in human (isoform CRA_a),mouse, dog and monkey and 86% homologous in opossum.

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.